Medindia

X

Centene's Pennsylvania Subsidiary Awarded Statewide Community HealthChoices Managed Care Agreement

Wednesday, August 31, 2016 General News J E 4
Advertisement

ST. LOUIS, Aug. 30, 2016 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that its Pennsylvania subsidiary, Pennsylvania Health & Wellness, has been selected by the departments of Human Services (DHS) and Aging to serve enrollees in the Community HealthChoices program statewide, pending regulatory approval and successful completion of readiness review.

The five-year agreement, with an option to renew for two additional years, is expected to commence July 1, 2017, in the Southwest zone. The Southeast zone will go-live on January 1, 2018, and the remainder of the state will go-live on January 1, 2019. Under the agreement, Pennsylvania Health & Wellness will coordinate physical health and long-term services and supports (LTSS), if needed, to enhance the quality of medical care and access to all appropriate services to more than 420,000 individuals who are dually eligible for Medicare and Medicaid, older Pennsylvanians and individuals with disabilities.

"Having grown up in Altoona, Pennsylvania, it is particularly rewarding that our 10th state managing care for participants in long term services and support programs is in Pennsylvania," said Michael F. Neidorff, Chairman, President and CEO for Centene. "Centene serves more than 210,000 participants in managed LTSS programs and today, we have the largest managed LTSS membership. We look forward to bringing our expertise to the Commonwealth, giving participants more choice in their healthcare options and empowerment to help them lead healthy lifestyles."

"Pennsylvania Health & Wellness is humbled to be selected to serve Pennsylvanians who are dually eligible for Medicare and Medicaid, and individuals with physical disabilities," said Brent Layton, Executive Vice President and Chief Business Development Officer for Centene. "We share a common goal with the Commonwealth of increasing opportunities for these individuals to live healthy lifestyles in their homes and in their communities. We look forward to bringing our comprehensive, integrated healthcare programs and services to Pennsylvanians and enable all beneficiaries to live in the least restrictive setting."

About Centene CorporationCentene Corporation, a Fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), as well as programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://www.centene.com/investors.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centenes-pennsylvania-subsidiary-awarded-statewide-community-healthchoices-managed-care-agreement-300320346.html

SOURCE Centene Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
MiMedx Provides Update On Key Clinical Trials
S
Top Five Things to Know About COBRA